Incipiam Pharma ApS — Credit Rating and Financial Key Figures

Incipiam Pharma ApS (CVR number: 44074214) is a company from RUDERSDAL. The company recorded a gross profit of -97.8 kDKK in 2024. The operating profit was -128 kDKK, while net earnings were -128 kDKK. The profitability of the company measured by Return on Assets (ROA) was -5.6 %, which can be considered poor and Return on Equity (ROE) was -5.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -2.2 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Incipiam Pharma ApS's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.